EMA's transparency seems to be opaque

被引：5

作者：

Banzi, Rita ^{[1
]}

Bertele', Vittorio ^{[1
]}

Garattini, Silvio ^{[1
]}

机构：

[1] IRCCS Ist Ric Farmacol Mario Negri, I-20156 Milan, Italy

来源：

LANCET | 2014年 / 384卷 / 9957期

关键词：

D O I：

10.1016/S0140-6736(14)62241-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1847 / 1847

页数：1

共 50 条

[1] Fostering EMA's transparency policy
Banzi, Rita
Bertele', Vittorio
Demotes-Mainard, Jacques
Garattini, Silvio
Gluud, Christian
Kubiak, Christine
Ohmann, Christian
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (08) : 681 - 684
[2] Opaque transparency
Grossman, WM
SCIENTIFIC AMERICAN, 1998, 279 (03) : 42 - 42
[3] Transparency: an opaque illustration
Shashok, Karen
Melero, Remedios
NATURE, 2016, 531 (7592) : 35 - 35
[4] Opaque Transparency: Why California's Supply Chain Transparency Act is Unenforceable
Greer, Benjamin Thomas
ONATI SOCIO-LEGAL SERIES, 2018, 8 (01): : 32 - 49
[5] EMA RESPONDS POSITIVELY TO EAHP'S TRIAL TRANSPARENCY CONCERNS
Price, Richard
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2014, 21 (05): : 313 - 313
[6] EMA adopts transparency policy
Nature Biotechnology, 2014, 32 (11) : 1076 - 1076
[7] EMA Transparency through Standards
不详
FLEISCHWIRTSCHAFT, 2013, 93 (03): : 85 - 85
[8] Transparency at the EMA: More Evidence Is Needed
Ragnar E. Löfstedt
Therapeutic Innovation & Regulatory Science, 2013, 47 : 299 - 300
[9] EMA publishes consultation on trial transparency
Price, Richard
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2013, 20 (05): : 318 - 318
[10] Transparency at the EMA: More Evidence Is Needed
Loefstedt, Ragnar E.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (03) : 299 - 300